Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- ISCTM Meeting Discusses Clinical And Regulatory Aspects Of Using Adaptive Designs In Clinical Trials For Central Nervous System Drug Approvals
- Wearable Kidney May Replace Dialysis Machine
- Pharmacists Have Solution To Address White House's Economic Case For Health Care Reform
- Senate Bill Would Give FDA Subpoena Power
- First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University Of Wisconsin Riverview Cancer Center
- FDA Approves New Lead for Chronic Pain
- CombinatoRx'S Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial
- Women Are At Greater Risk Than Men Of Graft Loss After Undergoing Liver Transplantation For Hepatitis C-related Liver Disease
- Medtronic Launches Clinical Trial To Improve Quality Of Care For Implantable Defibrillator Patients
- HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject For Second Phase II Study
Pharmaceutical Society of Australia Welcomes Electronic Health Record Recommendations
Posted by: admin in Pharmacy, Pharmacy Drugs on May 04th, 2009
The release by the National Health and Hospitals Reform Commission of its report focussing on e-health and
the introduction of a ‘person-controlled electronic health record’ has been welcomed by the Pharmaceutical Society of Australia.
The report recommends that by 2012 every Australian should have a personal electronic health record which
that person will own and have full control over.
The Acting President of the PSA, Dr Shane Jackson, said the NHHRC report addressed concerns expressed
about the National E-Health Strategy which proposed a 10-year time frame for the adoption of electronic health
initiatives.
“The PSA has long maintained that the 10-year proposal as outlined in the E-Health Strategy was unrealistic
and did not meet the best interests of the Australian public,” Dr Jackson said.
“It is refreshing to see the NHHRC moving to speed up the process of introducing electronic health records
which PSA believes are an important step in the improving the ongoing health-care needs of all Australians.
“PSA welcomes the accelerated timetable proposed by the NHHRC. PSA supports the widespread and
comprehensive use of electronic health records for recording the supply of medications and also supports the
recommendation that all healthcare providers have an obligation to ‘transmit’ key data, such as dispensed
medications. Whilst we support that all healthcare providers transmit key data, it must be acknowledged that
government needs to fund the infrastructure changes that need to be made for this to occur.”
The proposal would improve pharmacists’ ability to assist in the continuity of care for patients especially when
transitioning between the hospital and community and vice-versa.
“Also, by pharmacists having access to the relevant diagnostic and pathology information, it places us in a
much better position to detect and resolve any medication-related problems. The access to this diagnostic and
pathology information will also greatly facilitate any future prescribing role for pharmacists and the ability of
pharmacists to increase their role in Australia’s health-care system,” Dr Jackson said.
Dr Jackson said the report did not appear to propose that it be compulsory for patients to maintain an
electronic health record.
“PSA, however, supports the introduction of processes that foster greater participation in any such system. We
would urge an approach that encouraged opting out of the system, rather than opting in.”
Dr Jackson said the Government also needs to develop a strategy to inform consumers and health
professionals about the significant benefits and safeguards of the proposed NHHRC approach.
“Such an awareness-raising strategy is an important step in ensuring the acceptance and efficacy of the new
records system, which will be an essential pre-requisite to its success,” Dr Jackson said.
Dr Jackson said PSA would respond to other issues raised in the NHHRC report in the near future.
Source
Pharmaceutical
Society of Australia
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.